Portfolio
Advancing Portfolio
Screening Program
- RFP Year2020
- Awarded Amount$118,300
- DiseaseTuberculosis
- InterventionDrug
- Development StageHit Identification
- Collaboration PartnersDaiichi Sankyo RD Novare Co., Ltd., The Global Alliance for TB Drug Development